partnering

News

Amazon gathers Thread in decentralised trials alliance

Amazon's latest push into the healthcare arena is focusing on one of the top new trends in clinical research – the shift towards decentralised trials.

News

Sanofi's R&D platform building continues with $6bn-plus IGM ...

Sanofi has agreed another deal to flesh out its R&D pipeline, paying IGM Biosciences $150 million upfront to gain access to its engineered IgM antibody technology across six targets in

News

AZ expands digital health plans with Huma alliance

AstraZeneca has bought a stake in digital health firm Huma Therapeutics in a deal that will see ownership of AZ's AMAZE disease management platform transfer to the UK startup.

News

GSK partners LifeMine on fungi-derived medicines

GlaxoSmithKline has thrown its financial and drug development weight behind LifeMine Therapeutics, a US startup that aims to find new therapeutics from fungi – widely regarded as an underex

News

NICE’s track record in cancer drugs: the impact of the CDF and the role of interim funding

BMS buys into Volastra's cancer expertise with $1.1bn allian...

Bristol-Myers Squibb is the first big pharma to strike a deal with Volastra Therapeutics, a start-up that has developed a drug discovery platform based on chromosomal instability (CIN), a c

News

engineering and genetic editing through the Crispr technique. DNA chain breaking down. 3D rendering

Novartis puts up $1.7bn for Voyager's gene therapy platform

Voyager Therapeutics has signed another big pharma partner for its TRACER adeno-associated virus (AAV) vector technology, designed to improve the safety of gene therapies, with Novartis tak

Amazon gathers Thread in decentralised trials alliance

Sanofi's R&D platform building continues with $6bn-plus IGM ...

AZ expands digital health plans with Huma alliance

GSK partners LifeMine on fungi-derived medicines

BMS buys into Volastra's cancer expertise with $1.1bn allian...

Novartis puts up $1.7bn for Voyager's gene therapy platform

US pharma tariffs of up to 100% finalised by Trump

Using AI-driven synthetic personas to take your insights fur...

partnering

Editor's Picks